Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK InhibitionOlga K. Mirzoeva, W. Michael Korn, Debopriya Das et al.|Cancer Research|2009Cited by 390
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rachel Schiff, Rinath Jeselsohn et al.|Proceedings of the National Academy of Sciences|2016Cited by 185
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Clinical Cancer Research|2015Cited by 119
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinaseXiaoyong Fu, Rachel Schiff, Vijetha Kumar et al.|Breast Cancer Research|2014Cited by 70
Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cellsLanfang Qin, Rachel Schiff, M. Hahn et al.|Cancer Research|2015Cited by 1